Women with obesity and diabetes taking weight loss and diabetes drugs Mounjaro and Zepbound for over a year lost more weight than their male counterpa

Women Taking Mounjaro And Zepbound Lose More Weight Than Men, New Study Suggests: What To Know

submited by

Style Pass

2024-09-16 20:00:06

Women with obesity and diabetes taking weight loss and diabetes drugs Mounjaro and Zepbound for over a year lost more weight than their male counterparts—but also experienced more nausea and vomiting, according to new research.

Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in ... [+] a pharmacy in Krakow, Poland on April 9, 2024. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Researchers from Eli Lilly who tracked weight changes for a group of 4,677 people with Type 2 diabetes and obesity found female participants lost up to 24.6% of their body weight during treatment, while males lost up to 18.1% of their body weight.

The participants—2,999 females and 1,678 males—were followed for between 72 and 88 weeks, according to research presented this week at the Annual Meeting of The European Association for the Study of Diabetes.

These participants took different doses of once weekly tirzepatide—the generic name for Eli Lilly’s Mounjaro and Zepbound—shots during this time period.